Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesClinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: Single-center experience
Clinical Neurology and Neurosurgery, 09/02/09
Jeon HJ et al. – The median and 2-year survival outcomes in this study are comparable to the previous reports.
Methods- 79 patients with pathologically-confirmed glioblastomas were treated with radiotherapy combined with temozolomide, followed by adjuvant temozolomide
- Median OS was 18.3 mos and the TTP was 6.7 mos
- 1-y and 2-y survival rates were 70.1% and 37.1%, respectively
- The patients with a post-operative KPS > 80 showed more prolonged survival than those who had a KPS < 80 (23.1 mos vs. 13.4 mos)
- Hematologic toxicity occurred in 8.8% of patients
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Glioblastoma Proto-oncogene SEC61gamma Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress
Cancer Research, 12/10/09
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Cancer Research, 12/10/09
Time Trends in Brain Tumor Incidence Rates in Denmark, Finland, Norway, and Sweden, 1974–2003
Journal of the National Cancer Institute, 12/10/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: An economic evaluation
European Journal of Cancer, 12/10/09
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
European Journal of Cancer, 12/10/09
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
European Journal of Cancer, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor